Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BBSome complex member BBS7 is a core protein subunit of the BBSome, an octameric protein complex crucial for protein trafficking to the primary cilium membrane in eukaryotic cells[1][2][3][7][8]. BBS7 forms a tight dimer with BBS2 via a coiled-coil interaction; this dimer, together with BBS9, forms a central platform for BBSome complex assembly[1][3][4]. The BBSome acts as a coat complex, selecting and promoting correct membrane protein localization within cilia, which is essential for proper ciliary signaling. Mutations in BBS7 disrupt BBSome assembly, leading to the multisystemic disorder Bardet-Biedl syndrome, characterized by symptoms including retinal degeneration, obesity, renal dysfunction, and male infertility due to ciliary dysfunction[2][5]. BBS7 does not currently serve as a direct drug target or biomarker, nor is it classed as a classical pharmacological target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BBSome complex member BBS7 (BBS7).